Home/Xylo/Joshua Ismin

JI

Joshua Ismin

Chief Executive Officer, Co-founder

Therapeutic Areas

Psychiatric Disorders Neurological Disorders

Xylo Pipeline

Drug	Indication	Phase
Novel 5-HT Neurotherapeutic Programs	Psychiatric & Neurological Disorders (e.g., Depression, PTSD)	Preclinical

Leadership Team at Xylo

Dr. Sam Banister

Chief Scientific Officer, Co-founder

Chief Financial Officer

Dr. Jack Nguyen

Vice President of Research & Development

View full Xylo profile